Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines

Vaccine

Volumn 19, Issue 32, 2001, Pages 4652-4660

  Livingston, Brian D ^a   Newman, Mark ^a   Crimi, Claire ^a   McKinney, Denise ^a   Chesnut, Robert ^a   Sette, Alessandro ^a  

^a Epimmune   (United States)

Author keywords

DNA; Epitope; Vaccines

Indexed keywords

DNA VACCINE; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BIOASSAY; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DATA BASE; DNA FLANKING REGION; GENE CONSTRUCT; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AIDS VACCINES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGEN PRESENTATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATABASES, FACTUAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; H-2 ANTIGENS; HIV; HIV ANTIGENS; HLA-A ANTIGENS; HUMANS; INTERFERON TYPE II; JURKAT CELLS; MICE; MICE, TRANSGENIC; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDES; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINES, DNA;

EID: 0035860626     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00233-X     Document Type: Article

References (30)

1. T lymphocyte responses in HIV-1 infection: Implications for vaccine development
2. A new era for cancer immunotherapy based on the genes that encode cancer antigens
3. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
4. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
5. CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope
6. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues
7. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes
8. Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen
9. Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes
10. The induction of virus-specific CTL as a function of increasing epitope expression: Responses rise steadily until excessively high levels of epitope are attained
11. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses
12. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines
13. Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: Implications for vaccine design
14. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes
15. Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes
16. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination
17. An HLA-A2 polyepitope vaccine for melanoma immunotherapy
18. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome
19. Characterization of an in situ IFN-γ ELISA assay which is able to detect specific peptide responses from freshly isolated splenocytes induced by DNA minigene immunization
20. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
21. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif
22. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans
23. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
24. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
25. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
26. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes
27. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein
28. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1
29. An algorithm for the prediction of proteasomal cleavages
30. The specificity of proteasomes: Impact on MHC class I processing and presentation of antigens